Form 4: BioAtla Director Scott Smith Acquires 16,500 Shares of Common Stock
SEC Form 4 Filing
Director Scott Smith acquired 16,500 shares of BioAtla, Inc. common stock through a restricted stock unit award.
Summary
- On June 13, 2024, Scott Andrew Smith, a director of BioAtla, Inc., acquired 16,500 shares of common stock.
- The acquisition was through a time-based restricted stock unit (RSU) award.
- The RSU will vest as to 100% of the total number of shares on the earlier of June 13, 2025, or the next Company annual meeting of stockholders, subject to continued service.
- Following the transaction, Smith directly owns 304,593 shares of BioAtla common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director, which can be seen as a slightly positive sign of confidence, but it's not a major event.
Positives
- A director increasing their stake in the company can be seen as a positive signal.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors seeking insights into management's confidence in the company's prospects.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date of transaction: Scott Smith acquired 16,500 shares of BioAtla common stock. |
| 06/13/2025 | Vesting date of the restricted stock unit award, contingent on continued service, or earlier if the next annual meeting occurs before this date. |
| 06/14/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.